The Autoimmune Disease Therapies Boom: A New Era of Medical Miracles? The pharmaceutical industry's latest reports reveal a significant growth in autoimmune disease therapies.
By 2032, AbbVie's Skyrizi is expected to surpass $33 billion in revenue. This trend is not just driven by financial factors but also reflects remarkable advancements in medical research and treatment.
Advances in immunology have led to breakthroughs in treating conditions caused by self directed immune system attacks.